1. Home
  2. AA vs BBIO Comparison

AA vs BBIO Comparison

Compare AA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alcoa Corporation

AA

Alcoa Corporation

HOLD

Current Price

$61.91

Market Cap

15.7B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$66.18

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AA
BBIO
Founded
1888
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
15.3B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
AA
BBIO
Price
$61.91
$66.18
Analyst Decision
Buy
Strong Buy
Analyst Count
10
23
Target Price
$45.30
$82.26
AVG Volume (30 Days)
6.6M
3.0M
Earning Date
04-23-2026
05-22-2026
Dividend Yield
0.63%
N/A
EPS Growth
1580.77
N/A
EPS
4.37
N/A
Revenue
$12,831,000,000.00
$502,076,000.00
Revenue This Year
$9.98
$85.55
Revenue Next Year
$1.55
$71.10
P/E Ratio
$17.78
N/A
Revenue Growth
7.87
126.26
52 Week Low
$21.53
$28.33
52 Week High
$66.95
$84.94

Technical Indicators

Market Signals
Indicator
AA
BBIO
Relative Strength Index (RSI) 53.82 36.67
Support Level $55.17 $61.54
Resistance Level $65.87 $68.71
Average True Range (ATR) 3.24 3.91
MACD 0.14 -0.72
Stochastic Oscillator 62.70 11.61

Price Performance

Historical Comparison
AA
BBIO

About AA Alcoa Corporation

Alcoa is a vertically integrated aluminum company whose operations include bauxite mining, alumina refining, and manufacturing primary aluminum. It is one of the world's largest bauxite miners and alumina refiners by production volume, but sits outside the top-10 aluminum producers, a list dominated by Chinese companies. Profits are closely tied to prevailing commodity prices along the aluminum supply chain.Alcoa was the first mass producer of aluminum, launching the world-changing Hall-Heroult smelting process in the 1880s, making aluminum affordable. It listed as a public company in 1925. In 2016, Alcoa spun off its automotive and aerospace metal parts segment to focus on mining, smelting, and refining. It bought the 40% unowned balance of AWAC in mid-2024.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: